Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs )
Also on site :
- Sungrow's C&I BESS PowerStack Powers the Netherlands' Poultry Farm
- Queclink bringt GL52RP auf den Markt: Kompakter LoRa-Tracker zur langfristigen Sicherung von Vermögenswerten
- Queclink lanza GL52RP: rastreador LoRa compacto diseñado para la seguridad de activos a largo plazo